HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I INFECTION IN A JAPANESE IMMIGRANT POPULATION IN HAWAII NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I INFECTION IN A JAPANESE IMMIGRANT POPULATION IN HAWAII

Diss Abstr Int [B]; 51(5):2307 1990. Unique Identifier : AIDSLINE ICDB/91669594
Ho GYF; Johns Hopkins Univ.


Abstract: A cross-sectional study on HTLV-I infection was conducted in Japanese families originated from Okinawa, an HTLV-I endemic area in Japan, and now residing in Hawaii, a non-endemic area. The aim of the study was to examine the seroprevalence, factors related to transmission, and health implications of HTLV-I infection. The fathers of these families were first identified from the cohort of a prospective study established in 1965. Stored sera of the fathers collected in 1967-1975 were tested for HTLV-I antibodies. The seropositive fathers and a random sample of seronegative fathers were the index subjects for this study. The index subjects and their family members, including wives, children, and spouses of the children, were studied. Sera were collected and tested for HTLV-I antibodies, and data on factors related to transmission and health markers were obtained via questionnaire. The HTLV-I seroprevalence in the fathers was 11.4% in 1967-1975. When their sera were tested again in this study in 1987-1988, no seroconversion or seroreversion was detected. Seroprevalence in the wives was 11.4% and 41.2% among those whose husbands were seronegative and seropositive, respectively (p less than 0.001); it also increased significantly with the HTLV-I antibody levels of the husbands. Transmission of HTLV-I, perhaps through sexual contact, in married couples was suggested. A substantially low seroprevalence of HTLV-I was found among the children (about 1%). Infectivity in the parents, who lived in a non-endemic area, might be relatively low, and this could be responsible for the low seroprevalence in the offspring-generation. HTLV-I seropositivity was not related to sanitary condition in the household and degree of contact among household members. Casual contact might not be an important route of transmission of HTLV-I. As compared to the seronegative subjects, the seropositive subjects had a lower participation rate in this study and lower levels of white blood cells, red blood cells, hematocrit, and hemoglobin; they were also more likely to have been hospitalized and have acupuncture treatments. HTLV-I infection might have some subtle health effects on the host. (Full text available from University Microfilms International, Ann Arbor, MI, as Order No. AAD90-30201)
Keywords: Cross-Sectional Studies Female Hawaii Human HTLV-I Antibodies/ANALYSIS HTLV-I Infections/*EPIDEMIOLOGY/TRANSMISSION Japan/ETHNOLOGY Male THESISKWDcross-sectionalstudiesfemalehawaiihumanhtlv-iantibodies/analysishtlv-iinfections/KWDepidemiology/transmissionjapan/ethnologymalethesis
910430
M9140687

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .